Literature DB >> 14669789

Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells.

Akira Kido1, Sabine Krueger, Carsten Haeckel, Albert Roessner.   

Abstract

Aminopeptidase N (APN/CD13), a Zn2+-dependent ectopeptidase, is localized on the cell surface and functions as a transmembrane protein. Increased expression and activity of APN have been postulated to correlate with the aggressive behavior of several tumor types. In this study, the osteosarcoma cell line MNNG/HOS was stably transfected with an expression vector capable of expressing the antisense transcript of APN. Four stably transfected clones, the control clones and parental cells were characterized. Stable integration of the antisense vector was confirmed by PCR analysis of genomic DNA. Competitive RT-PCR revealed that mRNA expression of antisense-transfectants was decreased to approximately 37% of the control cell line. The activity assay showed that the enzymatic activity of APN was inhibited to approximately 51% of the control cell line. Antisense-transfection had no influence on the cellular proliferation measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, on the motility in Transwell chambers, and on the adhesive potential to collagen I. However, an in vitro invasion assay revealed a significant decrease in the number of cells that migrated through a reconstituted membrane (51% of the control cell line). The adhesive potential to Matrigel was also affected (73% of the control cell line). Furthermore, under in vivo conditions, a reduced potency to metastasize to the lung was shown in an experimental metastasis assay in nude mice. These findings demonstrate that APN plays an active role in the cellular attachment and proteolytic degradation of the extracellular matrix in the metastatic process of osteosarcomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14669789      PMCID: PMC7087608          DOI: 10.1023/a:1027383729767

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  29 in total

Review 1.  Specific regulation of gene expression by antisense, sense and antigene nucleic acids.

Authors:  C Hélène; J J Toulmé
Journal:  Biochim Biophys Acta       Date:  1990-06-21

2.  Surface aminopeptidase activity of human lymphocytes. I. Biochemical and biologic properties of intact cells.

Authors:  A A Amoscato; J W Alexander; G F Babcock
Journal:  J Immunol       Date:  1989-02-15       Impact factor: 5.422

3.  Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells.

Authors:  A Menrad; D Speicher; J Wacker; M Herlyn
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

4.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Authors:  L A Liotta; R H Goldfarb; R Brundage; G P Siegal; V Terranova; S Garbisa
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

5.  Antitumor activity of actinonin in vitro and in vivo.

Authors:  Y Xu; L T Lai; J L Gabrilove; D A Scheinberg
Journal:  Clin Cancer Res       Date:  1998-01       Impact factor: 12.531

6.  Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13.

Authors:  H Fujii; M Nakajima; I Saiki; J Yoneda; I Azuma; T Tsuruo
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

7.  Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.

Authors:  B F Sloane; K V Honn; J G Sadler; W A Turner; J J Kimpson; J D Taylor
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

8.  Monoclonal antibodies detect monocyte/macrophage activation and differentiation antigens and identify functionally distinct subpopulations of human rheumatoid synovial tissue macrophages.

Authors:  A E Koch; J C Burrows; A Skoutelis; R Marder; P H Domer; B Anderson; S J Leibovich
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

Review 9.  Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

10.  Inhibition of alanyl aminopeptidase induces MAP-kinase p42/ERK2 in the human T cell line KARPAS-299.

Authors:  U Lendeckel; T Kähne; M Arndt; K Frank; S Ansorge
Journal:  Biochem Biophys Res Commun       Date:  1998-11-09       Impact factor: 3.575

View more
  13 in total

1.  Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis.

Authors:  Yan Gu; Chen-Fang Zhu; Hitoshi Iwamoto; Ji-Sheng Chen
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

2.  Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma.

Authors:  Yan Gu; Cheng-Fang Zhu; Ya-Lei Dai; Qiang Zhong; Bo Sun
Journal:  World J Gastroenterol       Date:  2009-10-21       Impact factor: 5.742

3.  CD13 is a useful tool in the differential diagnosis of meningiomas with potential biological and prognostic implications.

Authors:  Stefano Marletta; Claudio Luchini; Nicola Sperandio; Evelin Torresani; Alessandro Sorio; Ilaria Girolami; Aldo Scarpa; Albino Eccher; Claudio Ghimenton
Journal:  Virchows Arch       Date:  2022-02-25       Impact factor: 4.535

4.  Differential expression of CD10 in prostate cancer and its clinical implication.

Authors:  Marc A Dall'Era; Lawrence D True; Andrew F Siegel; Michael P Porter; Tracy M Sherertz; Alvin Y Liu
Journal:  BMC Urol       Date:  2007-03-02       Impact factor: 2.264

5.  Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer.

Authors:  Li Pang; Nan Zhang; Yan Xia; Dawei Wang; Guoqing Wang; Xiangwei Meng
Journal:  Oncotarget       Date:  2016-11-22

6.  Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide.

Authors:  Konstantin Byrgazov; Claes Anderson; Benjamin Salzer; Eva Bozsaky; Rolf Larsson; Joachim Gullbo; Manfred Lehner; Fredrik Lehmann; Ana Slipicevic; Leo Kager; Mårten Fryknäs; Sabine Taschner-Mandl
Journal:  Ther Adv Med Oncol       Date:  2020-07-29       Impact factor: 5.485

7.  Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma.

Authors:  Torsten Kessler; Ariane Baumeier; Caroline Brand; Michael Grau; Linus Angenendt; Saliha Harrach; Ursula Stalmann; Lars Henning Schmidt; Georg Gosheger; Jendrik Hardes; Dimosthenis Andreou; Johannes Dreischalück; Georg Lenz; Eva Wardelmann; Rolf M Mesters; Christian Schwöppe; Wolfgang E Berdel; Wolfgang Hartmann; Christoph Schliemann
Journal:  Transl Oncol       Date:  2018-08-17       Impact factor: 4.243

Review 8.  Aminopeptidase N (CD13) as a target for cancer chemotherapy.

Authors:  Malin Wickström; Rolf Larsson; Peter Nygren; Joachim Gullbo
Journal:  Cancer Sci       Date:  2011-01-30       Impact factor: 6.716

9.  Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.

Authors:  Mikio Terauchi; Hiroaki Kajiyama; Kiyosumi Shibata; Kazuhiko Ino; Akihiro Nawa; Shigehiko Mizutani; Fumitaka Kikkawa
Journal:  BMC Cancer       Date:  2007-07-27       Impact factor: 4.430

10.  Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro.

Authors:  Anxun Wang; Bin Zhang; Hongzhang Huang; Leitao Zhang; Donglin Zeng; Qian Tao; Jianguang Wang; Chaobin Pan
Journal:  BMC Cancer       Date:  2008-06-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.